Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.

Mobilization of the T-cell response against cancer has the potential to achieve long-lasting cures. However, it is not known how to harness antigen-presenting cells optimally to achieve an effective antitumor T-cell response. In this study, we show that anti-CD47 antibody-mediated phagocytosis of cancer by macrophages can initiate an antitumor T-cell immune response. Using the ovalbumin model antigen system, anti-CD47 antibody-mediated phagocytosis of cancer cells by macrophages resulted in increased priming of OT-IT cells [cluster of differentiation 8-positive (CD8⁺)] but decreased priming of OT-II T cells (CD4⁺. The CD4⁺ T-cell response was characterized by a reduction in forkhead box P3-positive (Foxp3⁺ regulatory T cells. Macrophages following anti-CD47-mediated phagocytosis primed CD8⁺ I cells to exhibit cytotoxic function in vivo. This response protected animals from tumor challenge. We conclude that anti-CD47 antibody treatment not only enables macrophage phagocytosis of cancer but also can initiate an antitumor cytotoxic T-cell immune response. [ABSTRACT FROM AUTHOR]